Lisa Urquhart

Journalist

An award-winning journalist with more than 20 years’ experience of covering the life sciences sector.

Lisa has held a number of roles including editor of Evaluate Vantage and biotechnology correspondent for the Financial Times. Her interests within biopharma include M&A and venture financing, alongside exploring health inequalities.